SARAH PATTERSON-WEBB: Open Payments
NPI 1578981999 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 9 companies in 2025. Trend: 2023 $436 · 2024 $488 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Blueprint Medicines Corporation | 1 | $24 |
| Incyte Corporation | 1 | $20 |
| Aveo Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: IMFINZI, Enhertu, Optune Gio, AYVAKIT, JAKAFI, FOTIVDA, KISQALI, Epkinly.
Industry payments across AL — which companies pay providers there.
